Scientists Create Electric Comb That Could Transform Hair Loss Treatment

Millions of people spend years trying to find an effective way to stop hair loss, often cycling through expensive treatments with mixed results. Now, researchers have developed an unusual electric comb that has produced results that could attract serious attention from anyone struggling with baldness. In experiments involving mice, the device helped restore almost all lost hair within just 28 days.

Called Detangle, the experimental device even outperformed minoxidil, the active ingredient in the popular hair-loss treatment Rogaine. Although the research is still at an early stage, its results have raised an interesting possibility: could an ordinary-looking comb eventually become another weapon against pattern baldness?

Scientists Developed A Comb With An Unusual Hair Growth Mechanism

The device was developed by researchers at Beihang University in China and is designed to treat androgenetic alopecia, commonly known as male or female pattern baldness. Unlike conventional treatments that rely on medication applied to the scalp or taken orally, Detangle combines electrical stimulation with the targeted delivery of therapeutic molecules.

At first glance, the invention looks similar to a regular hair comb. However, its specially designed teeth contain electrodes and compartments capable of holding substances intended to encourage hair growth. This arrangement allows the device to perform two functions simultaneously while being moved across the treated area.

The researchers explained their invention in a paper published in the scientific journal Nature Communications. They introduced the technology by writing, “Here, we report ‘Detangle’ (a name inspired by the animated film ‘Tangled’), a comb-shaped device engineered for AGA [androgenetic alopecia] treatment.”

The name references Disney’s animated film Tangled, which follows Rapunzel and her famously long hair. Given the subject of the research, the connection is particularly fitting, although the technology itself is considerably more complicated than an ordinary grooming tool.

The researchers wanted to address a problem that has limited some existing hair-loss treatments. Getting therapeutic substances through the skin and into the hair follicles can be difficult, meaning that treatments applied externally may not reach their intended targets efficiently.

How The Electric Comb Delivers Treatment Into Hair Follicles

Detangle uses a combination of electrical pulses and specially arranged comb teeth to improve the delivery of therapeutic molecules. Its design creates an electrical field around the hair follicles while gently lifting the skin during use, helping substances penetrate deeper than conventional external application.

The Electrical Pulses Help Treatments Reach Deeper

The comb features electrodes embedded in teeth of different heights. As the device moves across the skin, these electrodes produce tiny electrical pulses that help increase the permeability of cell membranes.

This process makes it easier for therapeutic molecules outside the cells to enter them. The different heights of the teeth also help generate a stronger electrical field around the treated area, allowing the system to reach deeper skin tissues.

According to the researchers, the technology can deliver therapeutic materials to hair follicle regions approximately 660 micrometers beneath the skin’s surface. The study also describes an electrical field that penetrates substantially deeper into follicular regions than conventional external application.

The researchers believe this delivery mechanism could help overcome one of the biggest obstacles associated with topical hair-loss treatments. Instead of relying entirely on substances travelling through the skin independently, Detangle uses electrical stimulation to assist their movement towards the targeted cells.

The Comb Carries Two Therapeutic Molecules

The electrical system is only one part of the invention. Detangle also contains compartments designed to hold two therapeutic molecules that target different biological factors associated with pattern baldness.

The first is a VEGFA plasmid, which carries genetic instructions that encourage the production of vascular endothelial growth factor A. This protein promotes the formation of new blood vessels around hair follicles, potentially improving their blood supply and creating conditions that support hair regeneration.

The second molecule is called SRD5A2 siRNA. It is designed to reduce the production of an enzyme involved in converting testosterone into dihydrotestosterone, commonly known as DHT.

These two treatments serve different purposes, allowing the researchers to address both blood vessel development and hormonal activity associated with hair loss. Their combined delivery is a central feature of the experimental technology.

Why Scientists Are Targeting DHT To Fight Pattern Baldness

Androgenetic alopecia is the most common form of pattern hair loss and affects both men and women. The condition is strongly associated with genetic susceptibility and the effects of androgens, particularly DHT, which can gradually cause sensitive hair follicles to shrink.

DHT is produced from testosterone with the help of an enzyme called steroid 5-alpha-reductase 2. In people whose hair follicles are genetically sensitive to the hormone, this process can contribute to progressive follicle miniaturization.

As affected follicles become smaller, they begin producing thinner and shorter hairs. Over time, some follicles may stop producing visible hair, creating the familiar patterns of thinning associated with baldness.

How The Two Treatments Work Together

Detangle attempts to address this process through two complementary approaches. Its VEGFA plasmid encourages blood vessel formation around hair follicles, while the SRD5A2 siRNA aims to reduce the production of the enzyme involved in DHT formation.

The electrical stimulation helps deliver both molecules into the targeted follicular cells. This means the device combines a delivery system with treatments designed to influence the biological processes associated with hair regeneration.

The researchers also investigated how electrical stimulation affected cellular activity. Their findings suggested that the combined treatment influenced how cells process energy and function, potentially supporting the regenerative process.

This combination makes Detangle different from treatments that focus primarily on one aspect of hair loss. However, its effectiveness in humans remains unknown, and researchers will need further studies to establish whether the same mechanisms produce comparable results in people.

Mice Regrew Almost All Their Lost Hair Within 28 Days

The most attention-grabbing part of the research came from the experiments involving mice with experimentally induced androgenetic alopecia. Researchers used testosterone to create a model of pattern hair loss, allowing them to compare Detangle against established medications.

The animals had their backs shaved before receiving their assigned treatments. The researchers then used Detangle on the affected areas once every three days for 28 days, while other groups received conventional treatments, including minoxidil and finasteride.

The results were striking, with the mice treated using Detangle experiencing hair regrowth across almost 100% of the shaved area. By comparison, the animals receiving minoxidil achieved approximately 70% hair regrowth over the same period.

The experimental comb also performed better than finasteride in the researchers’ comparisons. Further examinations revealed an increase in hair follicle numbers and improvements in blood flow around the treated skin.

What The Researchers Observed During Testing

The study examined several aspects of the treatment beyond simply measuring how much hair returned. Researchers investigated whether the device successfully delivered its therapeutic molecules and whether the treated skin showed signs of damage.

Their findings supported the idea that electrical stimulation could improve the delivery of genetic material into deeper skin tissues. The researchers also reported no noticeable harm to the skin during the experiments.

Some of the most important findings included:

• Near-complete hair regrowth: The treated mice recovered hair across almost the entire shaved area after 28 days.
• Better results than minoxidil: The experimental device achieved approximately 100% regrowth compared with roughly 70% in the minoxidil group.
• Improved follicle numbers: Examinations showed an increase in the number of hair follicles in treated areas.
• Greater blood flow: The treatment encouraged blood vessel development around follicles, improving circulation in the affected skin.
• Effective molecular delivery: Electrical stimulation helped therapeutic substances reach deeper follicular regions.

These findings provide an encouraging starting point for further research. However, the experiment involved a relatively short treatment period and an animal model, meaning the results cannot yet establish how well the device would work against human hair loss.

How Detangle Compares With Existing Hair Loss Treatments

Minoxidil and finasteride are two established medications used to treat androgenetic alopecia. Both work through different mechanisms, and their effectiveness varies between individuals.

Minoxidil is commonly applied directly to the scalp as a liquid solution or foam. It can help stimulate hair growth, although users generally need to maintain treatment to preserve its benefits.

Some people dislike the application process, particularly when using topical products regularly. Oral minoxidil is another treatment option under medical supervision, although it can cause unwanted hair growth elsewhere and other systemic side effects.

Finasteride works by reducing the production of DHT. By inhibiting the enzyme responsible for converting testosterone into DHT, it targets one of the hormonal processes associated with pattern baldness.

However, finasteride can cause side effects in some users, including sexual side effects. Its suitability also depends on individual circumstances and medical considerations.

Why Delivering Medication Directly Matters

The researchers identified limited drug delivery as an important challenge with conventional topical treatments. When substances are applied externally, only a portion may reach the deeper tissues where hair follicles are located.

Detangle attempts to overcome this limitation by using electrical stimulation to improve the movement of therapeutic molecules into follicular cells. Its design could therefore help researchers investigate ways of delivering treatments more precisely.

The study authors explained their thinking clearly: “Safe and efficient delivery remains the key to the treatment outcome of AGA.”

Their approach could eventually prove useful for other dermatological treatments if further research confirms that the technology can safely deliver therapeutic substances into deeper skin tissues.

Other Experimental Treatments Are Also Targeting Baldness

Detangle is part of a wider effort to develop alternatives for people experiencing pattern hair loss. Researchers are investigating different formulations and delivery methods that could improve existing medications or target biological processes associated with shrinking hair follicles.

One example is VDPHL01, an experimental extended-release oral formulation of minoxidil. Research has investigated its potential to encourage hair regrowth in men over a six-month treatment period.

Another development is TH07, a topical formulation combining finasteride, minoxidil and latanoprost. The experimental combination has been investigated for its ability to outperform individual ingredients used separately.

These approaches differ from Detangle because they rely on medication formulations rather than an electrically stimulated delivery system. However, they share an interest in improving the effectiveness of treatments for androgenetic alopecia.

The development of these alternatives also reflects the limitations of existing options. Some people experience only modest improvements with conventional medication, while others encounter side effects or struggle with the application process.

For people affected by persistent hair loss, additional treatment options could eventually provide greater flexibility. However, experimental findings need to be followed by rigorous human testing before any new approach can be considered an established treatment.

Could The Electric Comb Eventually Work In Humans?

Despite the impressive animal results, Detangle has not yet demonstrated that it can restore hair in people. The difference between producing regrowth in mice and treating human pattern baldness is considerable, and further research will be necessary before the device can be considered for clinical use.

Human hair follicles have different characteristics, and the patterns of hormonal sensitivity can vary considerably between individuals. Researchers will need to determine whether the device can deliver its therapeutic molecules effectively into human follicles and produce sustained improvements.

Several questions also remain unanswered. Scientists must establish the appropriate treatment frequency, determine how much therapeutic material should be delivered and investigate whether repeated electrical stimulation remains safe over longer periods.

Long-term safety will be particularly important because androgenetic alopecia is a condition that often requires ongoing management. A treatment that produces rapid regrowth during a short experiment must also demonstrate that its benefits can be maintained without causing unwanted effects.

The researchers have suggested that their delivery technology could eventually have applications beyond hair loss. Its ability to transport genetic material and other therapeutic substances into deeper skin tissues could make it relevant to other dermatological conditions.

However, those possibilities remain areas for future investigation rather than proven medical applications.

The Next Step Could Be Human Clinical Trials

The Detangle research offers an interesting direction for hair-loss treatment because it combines electrical stimulation with two therapeutic molecules targeting different aspects of follicle regeneration. Its performance in mice suggests that improving how treatments reach hair follicles could be an important area for future research.

Still, people experiencing baldness should not mistake the findings for an available cure. The device remains experimental, and the near-complete regrowth reported in the study occurred in mice rather than human patients.

The real test will come when researchers can establish whether Detangle produces comparable results in people while maintaining an acceptable safety profile. Until then, the electric comb remains a fascinating scientific development, with its most important challenge still ahead.